AISAP, a Tel Aviv, Israel-based firm offering an AI-powered level of care assisted prognosis (POCAD)™ resolution for the medical ultrasound trade, raised $13M in Seed funding.
The spherical was led by Harel Insurance coverage Investments & Monetary Companies Ltd. and Shoni High Ventures, L.P.
The corporate intends to make use of the funds to broaden operations and improvement efforts.
Co-founded by Adiel Am-Shalom, Ehud Raanani, Robert Klempfner, Ehud Schwammenthal and led by CEO Roni Attali, AISAP offers a POCAD™ resolution that provides AI-powered diagnoses together with “urgency rating” that permits medical suppliers to prioritize instances based mostly on the severity of the situation, a rating that measures the standard of the scan for operators, to make sure accuracy even when they’re much less conversant in conventional ultrasound gadgets, and Deep Studying AI capabilities that allow correct readings even with lower-quality photos from handheld machines. The answer may even present diagnoses of particular valves throughout the cardiovascular programs.
AISAP’s algorithms have been educated on greater than 300,000 research comprising over 24 million video clips, and the expertise has been validated by a variety of medical specialists from The Mayo Clinic, Inova Well being Basis, Jefferson Well being, Poriya Institute and extra.
FinSMEs
03/05/2024
